Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Search results

From Bioblast
Results 1 – 21 of 139
Advanced search

Search in namespaces:

  
  
  
  
  
  
  
  
  
  
  
  
  
  • ...s added to the [[N-pathway control state]] in a defined [[coupling-control state]]. |info=[[Flux control efficiency]], [[Gnaiger 2020 BEC MitoPathways]]
    2 KB (229 words) - 18:28, 1 January 2021
  • ...erentially as reference state, if mitochondria are studied with respect to N-pathway injuries. ...~ GM''<sub>P</sub>''). Low N/S flux control ratios indicate defects in the N-pathway upstream of the Q-junction.
    2 KB (300 words) - 19:14, 30 December 2020
  • ...TS competent N-linked substrate combinations) and the [[NS-pathway control state]] (N in combination with succinate). NS indicates respiration with a cockta |mitopedia concept=Respiratory control ratio
    1 KB (163 words) - 18:27, 1 January 2021
  • ...t|100px|link=http://www.bioblast.at/index.php/O2k-Publications: Topics|O2k-Publications: Topics]] [[File:SUIT-catg FNSGp.jpg|right|200px|link=Electron-transfer-pathway state|Electron-transfer-pathway states]]
    1 KB (202 words) - 10:02, 3 June 2020
  • ..., S(Rot) or S. Then the NS-S pathway control efficiency in the ET-coupling state is ...to the NS-state. The reversed protocol, adding N-substrates to a S-pathway control background does not provide a valid estimation of S-respiration with succin
    2 KB (288 words) - 18:30, 1 January 2021
  • ...ing N-type substrates to a [[S-pathway control state]] as the [[background state]] does not provide a valid estimation of S-linked respiration with succinat = List of publications: S and NS pathway control states =
    1 KB (163 words) - 18:28, 1 January 2021
  • ...alonic acid]]). In the N-pathway control state [[Electron-transfer-pathway state|ET pathway level 4]] is active. |info=[[Electron-transfer-pathway state]], [[Gnaiger 2020 BEC MitoPathways]]
    3 KB (409 words) - 08:06, 25 November 2023
  • ...y_state|N]], [[NS-pathway control state| NS]], [[Succinate pathway control state| S]]). SUIT-004 can be extended with the CIV assay module. ...n| ''P'']]-[[ET capacity| ''E'']]) with N substrates ([[PM-pathway control state|PM]]).
    2 KB (293 words) - 23:36, 12 April 2021
  • |abbr= [[Malate-anaplerotic pathway control state|Malate anaplerosis]] |info='''A:''' '''[[Malate-anaplerotic pathway control state|Malate anaplerotic pathway]]'''
    3 KB (429 words) - 12:04, 3 June 2020
  • ...rnatively to a '''Complex I-linked substrate state''' ([[N-pathway control state]]). == List of publications: Complex I ==
    2 KB (214 words) - 13:43, 3 November 2023
  • |description=[[File:SUIT-catg NS.jpg|right|300px|NS-pathway control]] ...pt in terms of convergent electron transfer to the [[Q-junction]] (pathway control). '''NS''' is the abbreviation for the combination of [[NADH]]-linked subst
    4 KB (604 words) - 08:32, 25 November 2023
  • ...ion_pathway_control_state|F]], F(N), [[FN]] and [[FNS]] pathways in OXPHOS state can be evaluated by using this SUIT protocol. ...n of malate used in this protocol, typically 0.1 mM, does not saturate the N-pathway; but saturates the F-pathway.
    3 KB (407 words) - 13:24, 5 June 2019
  • ...ed pathway control) in combination with [[succinate]] ([[S-pathway control state]]; S- or CII-linked) and one or several fatty acids, which are supplied to |info=[[Electron-transfer-pathway state]], [[Gnaiger 2020 BEC MitoPathways]]
    3 KB (403 words) - 19:58, 1 January 2021
  • ...n of malate used in this protocol, typically 0.1 mM, does not saturate the N-pathway; but saturates the F-pathway. :::+ F-pathway (3Oct-2M.1) can be compared to FN-pathway (5P) in OXPHOS state.
    2 KB (345 words) - 10:29, 18 September 2020
  • |abbr=[[Glutamate-anaplerotic pathway control state|Glutamate anaplerosis]] |info='''A:''' '''[[Glutamate-anaplerotic pathway control state|Glutamate anaplerotic pathway]]'''
    3 KB (401 words) - 11:30, 3 June 2020
  • ...r through the F-junction (which is typically rate-limiting relative to the N-pathway branch), but simultaneously generates FADH<sub>2</sub> and NADH and thus de |info=[[Electron-transfer-pathway state]], [[Gnaiger 2020 BEC MitoPathways]]
    3 KB (456 words) - 16:12, 13 January 2022
  • ...are designed to measure simultaneously O<sub>2</sub> flux and the Q-redox state in isolated mitochondria and permeabilized cells. ...t D072]] simultaneous determination of O<sub>2</sub> flux and the Q-redox state in isolated mitochondria and cells permeabilized previously to addition to
    4 KB (623 words) - 17:57, 13 December 2023
  • |info='''A''' Linear coupling control with NADH-linked substrates for isolated mitochondria, tissue homogenate an ...without the involvement of the [[complex II]] ([[Succinate pathway control state| S-pathway]]). It can be useful to understand the contribution and the acti
    3 KB (397 words) - 00:12, 13 April 2021
  • ...rylation|OXPHOS state]], and [[FN]]—[[FNS]]—[[S]] in the [[ET capacity| ET state]]. ...in the fatty acid oxidation (F) and fatty acid oxidation&NADH pathway (FN) control states.
    3 KB (412 words) - 12:33, 25 November 2020
  • ...OS]] with [[NS-pathway control state|NS substrates]]) and coupling/pathway control''' ...ET state ([[NS-pathway control state|NS]] and [[Succinate pathway control state|S]]). SUIT-011 can be extended with the CIV assay module.
    6 KB (951 words) - 15:35, 8 June 2020

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)